The Application segment of the Dental Desensitizer market is divided into three primary categories: Homecare, Professional In‑Office, and Over‑the‑Counter (OTC). Homecare products, typically supplied through dental practices for patient self‑administration, account for roughly 35 % of market revenue, driven by recurring purchases and adherence programs. Professional In‑Office applications, encompassing chair‑side treatments performed by clinicians, dominate with an estimated 45 % share, reflecting higher unit prices, procedural fees, and the clinical preference for immediate relief. The OTC segment, sold directly to consumers via pharmacies and e‑commerce channels, contributes about 20 % of total sales, buoyed by growing awareness of dental sensitivity and the convenience of self‑treatment. Together, these application categories shape the overall market size and inform the Dental Desensitizer segmentation framework, where each segment’s growth dynamics are linked to reimbursement policies, consumer education, and product innovation.